Norgestimate And Ethinyl Estradiol
Product Images NDC 53002-1733

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 53002-1733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structures (Chem Structures)

Chemical structures of Norgestimate, USP, and Ethinyl Estradiol, USP, shown as molecular diagrams with labeled atoms and bonds. These structures represent the active ingredients in the product Norgestimate and Ethinyl Estradiol by RPK Pharmaceuticals, Inc.*

FDA Label Image

Fig-c (Fig C)

An instructional illustration showing a hand holding a pill pack with labeled days 'SUN' and 'MON,' arrows indicating 'Start' and 'Week 2' positions for pill usage, captioned as Figure C. This diagram likely demonstrates how to begin and continue the dosing schedule for Norgestimate and Ethinyl Estradiol tablets.*

FDA Label Image

Fig-d (Fig D)

Illustration of two blister card designs for Norgestimate and Ethinyl Estradiol tablets with dosage strengths labeled as 0.25 mg/0.035 mg and multiple strengths including 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. Each card shows a hand guiding a tablet out of the wrapped blister for the day labeled Saturday, with weekly rows and days of the week indicated for scheduled daily use over four weeks. Both cards include a note that the package is not child resistant.*

FDA Label Image

Fig-e (Fig E)

An instructional diagram labeled Figure E showing a finger pointing to the start position on a calendar-style pill pack for Norgestimate and Ethinyl Estradiol. The days Tuesday and Wednesday are partially visible, with arrows indicating Week 1 and Week 2.*

FDA Label Image

Fig-f (Fig F)

An instructional diagram showing a weekly pill-taking schedule with circles representing days Sunday and Monday across four weeks. Arrows indicate progression from start through week 4, with an illustration of a finger holding a pill in the Week 4 Sunday circle. The diagram is labeled as Figure F.*

FDA Label Image

Img1-1 (Img1 1)

An illustrated medication guide showing a 28-day cycle for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg. It displays four rows labeled Week 1 to Week 4, each with seven pill slots representing days of the week. The active pills are indicated as blue, and the inactive pills are light green, emphasizing the cycle for taking active followed by inactive tablets.*

FDA Label Image

Img1 (Img1)

An instructional calendar diagram for Norgestimate and Ethinyl Estradiol Tablets USP 0.25 mg/0.035 mg showing a 28-day pill cycle. It displays four weeks of daily pill circles, with an arrow indicating the start each week. The diagram differentiates blue pills as active and light green pills as inactive. The note at the bottom cautions that the package is not child resistant and advises keeping medication out of reach of children.*

FDA Label Image

Img2-1 (Img2 1)

An instructional diagram for Norgestimate and Ethinyl Estradiol Tablets showing a 4-week pill schedule with columns for each day of the week (Sunday to Saturday). It distinguishes pill types by color: white to off-white, light blue, and blue pills are labeled active, while light green pills are inactive. The diagram includes dosage strengths for each pill type.*

FDA Label Image

Img2 (Img2)

Diagram for Norgestimate and Ethinyl Estradiol Tablets USP showing a 28-day pill regimen with four weeks labeled. It identifies the pills by color and activity: white to off-white, light blue, and blue pills are active; light green pills are inactive. Days of the week run Sunday through Saturday for each week.*

FDA Label Image

Img3 (Img3)

An illustration showing a vertical scale of pregnancy rates per 100 women in one year, from 'Fewer than 1 pregnancy' at the top to '85 or more pregnancies' at the bottom. The diagram lists contraceptive methods aligned with pregnancy rates, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Label Image (Lbl530021733)

Norgestimate and Ethinyl Estradiol oral tablets packaging label for a 28-day regimen with 28 tablets. The label includes dosage instructions to take one tablet daily as directed, space for patient and clinic information, prescription details, barcodes, and lot and expiration dates. The label identifies RPK Pharmaceuticals, Inc. as the labeler.*

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.